Course Access
- This topic has 1 reply, 2 voices, and was last updated 8 years ago by
.
-
Posts
-
Dear all,
Has anyone reviewed automated PET infusion delivery systems?
The basic design includes:
* a multi-dose vial of F-FDG (the radiopharmaceutical)
* a multi-patient/shared IV administration line
* a single-use patient administration line with a one-way valve to prevent backflow.
At the start of the day, the shared administration line is used to access a bag of saline and the multi-dose vial; these are loaded in to a cart and covered. The administration line has a valve which protrudes from the cart which is swabbed and a single-use patient IV administration line is attached for each new patient coming in that day. Typically this is 8-9 patients in a session.
The single-use patient administration line has a one-way check valve which prevent backflow and contamination of the same shared administration line/F-FDG which remains in use across multiple patients throughout the day.
Our Nuclear Medicine department is interested in using this technology (as it reduces occupational exposure to F-FDG) but we have some concerns about the safety of the valve in preventing infection between patients. I have found one small in vitro study which suggests that it is safe.
If anyone has any feedback on reviewing or using these machines (positive or negative), I would love to hear from you.
Many thanks,
DanielaDaniela Karanfilovska
Clinical Nurse Consultant
Infection Prevention & Healthcare Epidemiologyt 03 90762819 m 0427 703769
e D.Karanfilovska@alfred.org.auAlfred Health
55 Commercial Road
Melbourne VIC 3004
PO Box 315 Prahran
VIC 3181 Australia
[cid:image001.jpg@01D23069.9441B840]
Alfred Health incorporates The Alfred, Caulfield Hospital and Sandringham Hospital
http://www.alfredhealth.org.auCONFIDENTIALITY NOTICE: This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom it is addressed. If you have received this email in error, please notify us by return email and delete all copies in your system. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Alfred Health is not liable for the proper and complete transmission of the information contained in this communication or for any delay in its receipt.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
Hi Daniela:
Apologies for the delay in responding, just saw your mail.
I am declaring a vested interest as my employer manufactures products that may be relevant to your enquiry.
The Infusion Nurses Society Infusion Therapy Standards of Practice 2016 should be able to provide some guidance on what to do, as may the AVATAR group from Griffiths Uni in QLD (http://www.avatargroup.org.au/). Your hospital may already have a copy of this document (INS Infusion Therapy Standards of Practice 2016), but just in case, here is a link to their site: https://www.ins1.org/Store/ProductDetails.aspx?productId113266
One option may be to insert an inline IV filter (0.2 m, endotoxin- and/or bacterial-retentive) with each single-use patient IV administration set. The filter is typically the last device before the patient hub/port. This will ensure that should there be a failure in the check-valve, any contamination from the patient will remain on the patient/downstream-side of the filter, and any contamination introduced into the line from upstream will remain on the upstream side of the filter.
Your F-FDG drug manufacturer should be able to advise you on whether filters may be used with their product; your Clinical Products Advisor (Karen Flett) and Procurement Manager (Trish Jaksic) should be able to advise you on which IV filter manufacturer your hospital currently uses, and the filter manufacturer should be able to inform you whether or not F-FDG may be used with their filter.
Thanks, and regards
John Matthew
Marketing & Strategic Leader
Pall Medical, ANZ
M: +61 419 130 668
E: john_matthew@pall.com
W: http://www.pall.com[cid:image003.png@01D23F57.15E883F0]
Dear all,
Has anyone reviewed automated PET infusion delivery systems?
The basic design includes:
a multi-dose vial of F-FDG (the radiopharmaceutical)
a multi-patient/shared IV administration line
a single-use patient administration line with a one-way valve to prevent backflow.
At the start of the day, the shared administration line is used to access a bag of saline and the multi-dose vial; these are loaded in to a cart and covered. The administration line has a valve which protrudes from the cart which is swabbed and a single-use patient IV administration line is attached for each new patient coming in that day. Typically this is 8-9 patients in a session.
The single-use patient administration line has a one-way check valve which prevent backflow and contamination of the same shared administration line/F-FDG which remains in use across multiple patients throughout the day.
Our Nuclear Medicine department is interested in using this technology (as it reduces occupational exposure to F-FDG) but we have some concerns about the safety of the valve in preventing infection between patients. I have found one small in vitro study which suggests that it is safe.
If anyone has any feedback on reviewing or using these machines (positive or negative), I would love to hear from you.
Many thanks,
DanielaDaniela Karanfilovska
Clinical Nurse Consultant
Infection Prevention & Healthcare Epidemiologyt 03 90762819 m 0427 703769
e D.Karanfilovska@alfred.org.auAlfred Health
55 Commercial Road
Melbourne VIC 3004
PO Box 315 Prahran
VIC 3181 Australia
[cid:image001.jpg@01D23069.9441B840]
Alfred Health incorporates The Alfred, Caulfield Hospital and Sandringham Hospital
http://www.alfredhealth.org.auCONFIDENTIALITY NOTICE: This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom it is addressed. If you have received this email in error, please notify us by return email and delete all copies in your system. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Alfred Health is not liable for the proper and complete transmission of the information contained in this communication or for any delay in its receipt.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
Attention:
This communication may contain information that is confidential, privileged and/or exempt from disclosure under applicable law. If you are not the intended recipient, please notify the sender immediately and delete the original, all attachments, and all copies of this communication.
Please be advised that this email may contain confidential information. If you are not the intended recipient, please notify us by email by replying to the sender and delete this message. The sender disclaims that the content of this email constitutes an offer to enter into, or the acceptance of, any agreement; provided that the foregoing does not invalidate the binding effect of any digital or other electronic reproduction of a manual signature that is included in any attachment.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
- The forum ‘Infexion Connexion’ is closed to new topics and replies.